Institutional Manager · CIK 0001856083
Deep Track Capital, LP
GREENWICH, CT · File #028-21949
Latest AUM
$5.61B
Positions
55
Top-10 Concentration
60.3%
Filings
13
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORTQ/E Dec 202555 pos · $5.61B
- 13F HOLDINGS REPORTQ/E Sep 202556 pos · $3.58B
- 13F HOLDINGS REPORTQ/E Jun 202566 pos · $3.12B
- 13F HOLDINGS REPORTQ/E Mar 202569 pos · $3.09B
- 13F HOLDINGS REPORTQ/E Dec 202463 pos · $2.68B
- 13F HOLDINGS REPORTQ/E Sep 202471 pos · $3.15B
- 13F HOLDINGS REPORTQ/E Jun 202468 pos · $3.35B
- 13F HOLDINGS REPORTQ/E Mar 202466 pos · $3.49B
- 13F HOLDINGS REPORTQ/E Dec 202363 pos · $2.59B
- 13F HOLDINGS REPORT (Amended)Q/E Sep 202355 pos · $2.16B
- 13F HOLDINGS REPORTQ/E Sep 202358 pos · $2.43B
- 13F HOLDINGS REPORTQ/E Jun 202358 pos · $2.43B
- 13F HOLDINGS REPORTQ/E Mar 202360 pos · $2.38B
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | SPDR SERIES TRUST | 78464A870 | 10,000,000 | $1.22B | 21.78% |
| 2 | IMMUNOVANT INC | IMVT | 11,526,971 | $293.0M | 5.23% |
| 3 | GUARDANT HEALTH INC | GH | 2,800,000 | $286.0M | 5.11% |
| 4 | STRUCTURE THERAPEUTICS INC | GPCR | 4,111,782 | $286.0M | 5.11% |
| 5 | TARSUS PHARMACEUTICALS INC | TARS | 3,004,034 | $246.0M | 4.39% |
| 6 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 15,726,349 | $241.9M | 4.32% |
| 7 | CYTOKINETICS INC | CYTK | 3,336,998 | $212.0M | 3.79% |
| 8 | AXSOME THERAPEUTICS INC | AXSM | 1,150,000 | $210.0M | 3.75% |
| 9 | APELLIS PHARMACEUTICALS INC | APLS | 7,750,000 | $194.7M | 3.48% |
| 10 | VAXCYTE INC | PCVX | 4,000,000 | $184.6M | 3.30% |
| 11 | MAZE THERAPEUTICS INC | MAZE | 4,246,440 | $175.9M | 3.14% |
| 12 | VERA THERAPEUTICS INC | VERA | 2,821,135 | $142.9M | 2.55% |
| 13 | BIOMARIN PHARMACEUTICAL INC | BMRN | 2,300,000 | $136.7M | 2.44% |
| 14 | IONIS PHARMACEUTICALS INC | IONS | 1,700,000 | $134.5M | 2.40% |
| 15 | NURIX THERAPEUTICS INC | NRIX | 7,036,455 | $133.5M | 2.38% |
| 16 | MBX BIOSCIENCES INC | MBX | 3,249,790 | $102.5M | 1.83% |
| 17 | OCULAR THERAPEUTIX INC | OCUL | 8,070,414 | $98.0M | 1.75% |
| 18 | GRAIL INC | GRAL | 1,022,797 | $87.5M | 1.56% |
| 19 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,524,833 | $78.6M | 1.40% |
| 20 | LB PHARMACEUTICALS INC | LBRX | 3,352,804 | $74.6M | 1.33% |